BioSig Technologies, Inc. (BSGM) Starts Presentation at LD Micro Main Event
BioSig Technologies (OTC: BSGM) is a medical device company developing a proprietary technology platform designed to improve the $4.6 billion electrophysiology (EP) marketplace. Led by a proven management team and a veteran and independent Board of Directors, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP(TM) System. PURE EP is a novel cardiac signal acquisition and display system, engineered to assist electrophysiologists in clinical decision making during procedures to diagnose and treat patients with abnormal heart rates and rhythms. For more information, visit the company’s website at www.biosigtech.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides…







